Clinical Trials Browser

Phase 2 × pidilizumab × Gastrointestinal × Clear all

NCT01313416 2019-07-10

Gemcitabine and CT-011 for Resected Pancreatic Cancer

Phase 2 Terminated

2 enrolled 5 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00890305 2015-07-08

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms